Bibbins-Domingo K, Helman A, Dzau VJ (2022) The imperative for diversity and inclusion in clinical trials and health research participation. JAMA 327:2283–2284

Article  PubMed  Google Scholar 

Knepper TC, McLeod HL (2018) When will clinical trials finally reflect diversity? Nature 557:157–159

Article  CAS  PubMed  Google Scholar 

Tur C, Carvajal R, Otero-Romero S, Tintore M (2024) Generalizing the results of clinical trials if participants are not from diverse racial and ethnic groups. Neurology. https://doi.org/10.1212/WNL.0000000000209730

Article  PubMed  PubMed Central  Google Scholar 

Rosendale N, Wong JO, Flatt JD, Whitaker E (2021) Sexual and gender minority health in neurology: a scoping review. JAMA Neurol 78:747–754

Article  PubMed  PubMed Central  Google Scholar 

Pasquali SK, Lam WK, Chiswell K, Kemper AR, Li JS (2012) Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry. Pediatrics 130:e1269–e1277

Article  PubMed  PubMed Central  Google Scholar 

van Marum RJ (2020) Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol 86:2014–2016

Article  PubMed  PubMed Central  Google Scholar 

Cardenas-Iniguez C, Gonzalez MR (2024) Recommendations for the responsible use and communication of race and ethnicity in neuroimaging research. Nat Neurosci 27:615–628

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwartz AL, Alsan M, Morris AA, Halpern SD (2023) Why diverse clinical trial participation matters. N Engl J Med 388:1252–1254

Article  PubMed  Google Scholar 

International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ICH harmonised tripartite guideline studies in support of special populations: geriatrics E7 Current Step 4 version; 1993.

Inclusion of women and minorities as participants in research involving human subjects|Grants & Funding. https://grants.nih.gov/policy-and-compliance/policy-topics/inclusion/women-and-minorities.

NOT-OD-18–014: Revision: NIH policy and guidelines on the inclusion of women and minorities as subjects in clinical research. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-014.html.

White J, Tannenbaum C, Klinge I, Schiebinger L, Clayton J (2021) The integration of sex and gender considerations into biomedical research: lessons from international funding agencies. J Clin Endocrinol Metab 106:3034–3048

Article  PubMed  PubMed Central  Google Scholar 

Federal Register: Revisions to OMB’s statistical policy directive No. 15: standards for maintaining, collecting, and presenting federal data on race and ethnicity. https://www.federalregister.gov/documents/2024/03/29/2024-06469/revisions-to-ombs-statistical-policy-directive-no-15-standards-for-maintaining-collecting-and.

Porter NC, Morgenstern LB (2022) Racial and ethnic equity in neuromuscular care-time for our action to live up to potential. JAMA Neurol 79:1221–1222

Article  PubMed  Google Scholar 

Oksanen, J. et al. Community ecology package [R package vegan version 2.6–10]. CRAN: Contributed Packages; 2025. https://doi.org/10.32614/CRAN.PACKAGE.VEGAN.

Killick R, Eckley IA (2014) changepoint: an R package for changepoint analysis. J Stat Softw 58:1–19

Article  Google Scholar 

McCombe PA, Henderson RD (2010) Effects of gender in amyotrophic lateral sclerosis. Gend Med 7:557–570

Article  PubMed  Google Scholar 

Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC (2019) Incidence and prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysis. Neuroepidemiology 52:161–172

Article  PubMed  Google Scholar 

Theadom A et al (2019) Prevalence of Charcot-Marie-Tooth disease across the lifespan: a population-based epidemiological study. BMJ Open 9:e029240

Article  PubMed  PubMed Central  Google Scholar 

Wang Z et al (2021) Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study. Lancet Reg Health West Pac 18:100323

PubMed  PubMed Central  Google Scholar 

Yuki N, Hartung H-P (2012) Guillain-Barré syndrome. N Engl J Med 366:2294–2304

Article  CAS  PubMed  Google Scholar 

Paltiel AD et al (2015) Demographic and clinical features of inclusion body myositis in North America. Muscle Nerve 52:527–533

Article  PubMed  PubMed Central  Google Scholar 

Dimachkie MM, Barohn RJ (2014) Inclusion body myositis. Neurol Clin 32:629–646

Article  PubMed  PubMed Central  Google Scholar 

Motomura M, Nakata R, Shiraishi H (2016) Lambert-Eaton myasthenic syndrome: clinical review. Clin Exp Neuroimmunol 7:238–245

Article  CAS  Google Scholar 

Sciancalepore F et al (2024) Prevalence, incidence, and mortality of myasthenia gravis and myasthenic syndromes: a systematic review. Neuroepidemiology. https://doi.org/10.1159/000539577/914586/PREVALENCE-INCIDENCE-AND-MORTALITY-OF-MYASTHENIA

Article  PubMed  Google Scholar 

Poulas K, Tzartos SJ (2001) The gender gap in autoimmune disease. Lancet 357:234

Article  CAS  PubMed  Google Scholar 

Hernáez L et al (2024) Prevalence of Steinert’s myotonic dystrophy and utilization of healthcare services: a population-based cross-sectional study. Healthcare (Basel) 12:838

Article  PubMed  Google Scholar 

Vanacore N et al (2016) An age-standardized prevalence estimate and a sex and age distribution of myotonic dystrophy types 1 and 2 in the Rome province. Italy Neuroepidemiology 46:191–197

Article  PubMed  Google Scholar 

Souza FH, Levy-Neto M, Shinjo SK (2011) Prevalence of clinical and laboratory manifestations and comorbidities in polymyositis according to gender. Rev Bras Reumatol 51:428–483

Article  PubMed  Google Scholar 

Cox S, Limaye V, Hill C, Blumbergs P, Roberts-Thomson P (2010) Idiopathic inflammatory myopathies: diagnostic criteria, classification and epidemiological features. Int J Rheum Dis 13:117–124

Article  PubMed  Google Scholar 

Ramamoorthy A, Pacanowski MA, Bull J, Zhang L (2015) Racial/ethnic differences in drug disposition and response: review of recently approved drugs. Clin Pharmacol Ther 97:263–273

Article  CAS  PubMed  Google Scholar 

Beland B, Jewett G, Lee A, Perera T, Korngut L (2023) Sex differences in therapy for myasthenia gravis (P7–8.002). Neurology 100:3421

Article  Google Scholar 

Vinciguerra C et al (2023) Sex differences in neuromuscular disorders. Mech Ageing Dev 211:111793

Article  CAS  PubMed  Google Scholar 

Sun J, Harrington MA, Porter B (2023) Sex difference in spinal muscular atrophy patients—are males more vulnerable? J Neuromuscul Dis 10:847–867

Article  PubMed  PubMed Central  Google Scholar 

Vorster E, Essop FB, Rodda JL, Krause A (2020) Spinal muscular atrophy in the black South African population: a matter of rearrangement? Front Genet 11:54

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zamani A, Thomas E, Wright DK (2024) Sex biology in amyotrophic lateral sclerosis. Ageing Res Rev 95:102228

Article  CAS  PubMed  Google Scholar 

Roberts AL, Johnson NJ, Chen JT, Cudkowicz ME, Weisskopf MG (2016) Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology 87:2300–2308

Article  PubMed  PubMed Central  Google Scholar 

Abu